重磅！默克集团确定新任CEO

Core Viewpoint - Merck KGaA announced that Kai Beckmann will succeed Belén Garijo as the Chairman of the Executive Board and CEO starting May 1, 2026, ensuring a smooth leadership transition [1][4] Group 1: Leadership Transition - Belén Garijo has been with Merck for 15 years, serving as CEO of the Healthcare business for 6 years and as Chairman and CEO since 2021 [1][3] - Under Garijo's leadership, Merck maintained stable growth during the pandemic and geopolitical turmoil through organic growth and strategic acquisitions, such as the acquisition of SpringWorks [1][4] - Kai Beckmann has been with Merck since 1989 and has held various global management positions, including leading the high-performance materials business since 2017 [3] Group 2: Business Performance and Strategy - Merck operates in life sciences, healthcare, and electronics, employing over 62,000 people across 65 countries [4] - The company achieved sales of €21.2 billion in 2024, reflecting its strong market position [4] - The leadership change signifies Merck's commitment to leadership continuity and ongoing innovation in global technology and healthcare sectors [4]